Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Slashes Revenue Forecasts For 2010 And 2011 Due To Health Care Reform

Apr 19 2010

• By Ed Silverman

Related Content

Lilly Tries to Buy Time

Dec 01 2009

FDA's "Complete Response" Letter For Byetta LAR Isn't Too Onerous, Amylin Says

Mar 15 2010

Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification

Apr 12 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window